Patients with cerebral infarction can use hormones, but hormones themselves do not treat cerebrovascular disease. Patients who suffer from diseases such as myasthenia gravis or rheumatoid arthritis are treated with long-term oral hormones to relieve patients’ symptoms. During this period patients should not discontinue hormones if cerebral infarction disease suddenly occurs, because inappropriate discontinuation can lead to aggravation of myasthenia gravis in patients and lead to aggravation of rheumatoid arthritis pain in patients. The treatment of cerebral infarction patients does not require hormones. The treatment of cerebral infarction is mainly to activate blood circulation and improve blood circulation in the brain, and the choice of drugs is made according to the time of the patient’s visit and the cause of the disease, such as treatment by thrombolysis, fibrin-lowering, anticoagulation and anti-platelet aggregation. At the same time, patients are given treatment to promote the recovery of brain nerve function and improve the symptoms of cerebral infarction, and the use of hormones does not affect the patient’s cerebral infarction disease.